| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-07 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.21 | 4e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-06 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |